Miscellaneous Neurodegenerative Disorders Archives - Page 93 of 94 - MPR

Miscellaneous Neurodegenerative Disorders

Nuedexta approved for pseudobulbar affect

Avanir Pharmaceuticals announced that the FDA has approved Nuedexta (dextromethorphan hydrobromide and quinidine sulfate capsules) for the treatment of pseudobulbar affect (PBA).